RECELL® Spray-On Skin™ Cells for burn, trauma, or surgical wounds.
A powerful primary wound dressing that adheres in a single application
Discover the New FDA-Approved
RECELL GO System
AVITA Medical Reports Fourth Quarter Quarter and Full Year 2024 Financial Results
February 13, 2025
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
December 23, 2024
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 19, 2024
AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL® System, approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects. In the United States, AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix, and Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix.
We’re Changing Lives for the Better.
RECELL uses a small sample of the patient’s skin to create a suspension of Spray-On Skin™ Cells for the treatment of thermal burn wounds and full-thickness skin defects. This is prepared and applied at the point-of-care.
Focused Pipeline
with Strong
Growth Potential
We are currently exploring the potential of our novel technology platform to harness the healing
properties of a patient’s own skin across
a number of skin-related indications.
Join Our Team
We believe a great culture attracts and retains quality talent. That is why we have intentionally created, and continue to nurture, a high-performance, inspired culture with a collaborative work environment where we are all passionate about making a difference in patient’s lives.
